SlideShare a Scribd company logo
1 of 8
Download to read offline
clinicsofoncology.com 1
Research Article ISSN: 2640-1037 Volume 6
Clinics of Oncology
A Large Sample Single Center Study On Reducing the Incidence of Adverse Events
During Intravenous Pump-Used Infusion in Neonates by Root Cause Analysis
Shuzhen Zhu1*
, Lianjuan Zhou1
, Jun Yu1
, Caixian Zheng2
, Jihua zhu3*
and Kewen Jiang4*
1
Neonatology Department, Children’s Hospital Zhejiang University School of Medicine, National Clinical Research Center for Child
Health, 3333 Binsheng Road, Hangzhou 310051, China
2
Device Department, Children’s Hospital Zhejiang University School of Medicine, National Clinical Research Center for Child Health,
3333 Binsheng Road, Hangzhou 310051, China
3
Department of Nursing, Children’s Hospital Zhejiang University School of Medicine, National Clinical Research Center for Child
Health, 3333 Binsheng Road, Hangzhou 310051, China
4
Department of Child Psychology, The Children’s Hospital Zhejiang University School of Medicine, National Clinical Research Center
for Child Health, 3333 Binsheng Road, Hangzhou 310051, China
Keywords:
Intravenous administration; Neonate; Infusion
pump; Root cause analysis; Adverse event
Abbreviations:
Received: 05 May 2022
Accepted: 30 May 2022
Published: 04 Jun 2022
J Short Name: COO
Copyright:
©2022 Shuzhen Zhu. This is an open access article distrib-
uted under the terms of the Creative Commons Attribution
License, which permits unrestricted use, distribution, and
build upon your work non-commercially.
Citation:
Shuzhen Zhu, A Large Sample Single Center Study On
Reducing the Incidence of Adverse Events During Intra-
venous Pump-Used Infusion in Neonates by Root Cause
Analysis. Clin Onco. 2022; 6(7): 1-8
AE: Adverse Event; IP: Infusion Pump; RCA: Root Cause Analysis; SAC: Severity Assessment Code; SPSS: Statistical Product and Service Solutions
1. Abstract
Intravenous administration is one of the most critical activities in
neonatology, which directly involving the use of higher precision
infusion pumps. However, its related adverse events are still hap-
pened during the neonatal infusion. Root cause analysis, a program
to find the cause of an adverse event and prevent the same adverse
event from happening again, was used in this study. We enrolled a
large number of neonatal patients, and applied a pre–post design.
This study resulted in information of 12 adverse events (15,720
cases of infusion with infusion pump) amongst 4,624 patients. The
root cause analysis approach (8 months) produced 14 unique rec-
ommendations, 85.7% of which were completed. We found that
after the root cause analysis approach the overall safety of the
system of infusion pump-used infusions in neonatal practices has
greatly improved, and specifically a reduction in the incidence of
infusion pump alarming malfunction and infusion pump malfunc-
tion, and medication error due to the weak infusion pump safety
awareness and nonstandard infusion pump operation for junior
nurses. However, a system level root cause analysis study in which
nationally participating hospitals are randomly assigned to the root
cause analysis approach is needed.
2. Introduction
Intravenous infusion delivering drug, nutrient and fluid is a com-
mon therapeutic strategy in nursing. As a necessary clinical aux-
iliary equipment, infusion pump (IP) can accurately control the
total amount and flow rate of infusion and significantly reduce the
workload of nursing [1-3]. It has been widely used in pediatric
clinical practice including in neonatology. However, in the neo-
natal IP-related nursing, adverse events (AEs) such as failures of
infusion rate control, failures of IP alarming and other human fac-
*
Corresponding author:
Shuzhen Zhu,
Neonatology Department, Children’s Hospital
Zhejiang University School of Medicine,
National Clinical Research Center for Child
Health, 3333 Binsheng Road, Hangzhou 310051,
China, E-mail:jihuazhu@zju.edu.cn and
jiangkw_zju@zju.edu.cn
Volume 6 Issue 7 -2022 Research Article
clinicsofoncology.com 2
tors occurring from time to time [4,5]. These errors are difficult to
intercept, and their impact depends on multiple factors including
the patient's drugs and conditions 6, which not only increases the
suffering of patients, but also delays the recovery of diseases, in-
creases medical expenses and hospital stay, and even leads to neo-
natal death [7-9]. Therefore, ensuring greater safety of neonatal
patients during IP-used infusion should be a priority. It has been
reported that a number of strategies could reduce these IP-related
AEs over the past years [10-13]. However, the AEs may still occur
in neonatal infusion. The root cause analysis (RCA) approach is a
strategy dealing with AEs from the level of learning system [14].
It is a retrospective analysis tool to medical AEs, from finding out
the potential errors and their root causes to providing steps for pre-
vention and avoiding similar AEs happening again. In this study,
RCA was used prospectively in neonatology to deal with IP-used
Table 1. IP AEs that were tracked and their definition
infusion from May 2019 to April 2020 in a national children’s hos-
pital to explore prevention and improvement steps, with ultimate
goals to reduce the recurrence of AEs and ensuring the safety of
neonates.
3. Methods
3.1. Design
After approved by ethics board (2020-IRB-201; the Research Eth-
ics Board), this study was carried out at a national children’s hos-
pital. The need for participant consent was waived by the ethics
committee. This was a prospective study comparing differences
in the incidence of AEs (Table 1) with IP-used infusion before and
after the RCA approach. IP (SN-1600V, SINOMDT, Shenzhen,
China) was used in this study which would not be completely up-
date during the RCA approach. It was driven by matching software
(Version 1.0 to 4.0). When IP-related AE occurred, the software
should upgrade to the latest version at that time.
AE Definition
Cardiac arrest Sudden loss of cardiac function without pulses
Death Unable to be resuscitated
Hypoglycemia Blood glucose < 2.2 mmol/L
Hyperglycemia Blood glucose > 7.0 mmol/L
Medication error Problems including the wrong drug, dose, frequency, or route of administration
□ Wrong speed setting in IP program
IP malfunction Did not deliver the fluid as programmed
□ Uncontrolled infusion speed: Infusion speed too fast or too slow
□ Uncontrolled infusion rate: Ununiformed infusion speed (sometimes fast and sometimes slow)
IP programming error Errors with the IP setup or program was different from the doctor's order
□ Uncontrolled infusion volume: Infusion cumulative amount being inconsistent with the setting
□ Software system failure: A problem of speed settings causing the output speed to be inconsistent with the
preset
□ Fluid not be pumped in: Not giving liquid showing that the liquid does not drop or flow back
□ Sudden not working: Suddenly not running in infusion with no alarm and unable to reboot
IP mechanical failure Problems with the IP mechanical parts
□ IP screen failure: Incomplete information display, low bright screen, black screen or abnormal flicker
□ IP keys not working: Invalid or damaged keys
□ Battery failure: Sudden power off including internal power failure or unable to recharge
□ Door clamp out of order: Door unable to open or damaged
IP alarming malfunction Problems with the IP alarming system
□ Abnormal identifying: Not alarming or continuously light-alarming dues to unable to identify the pipeline
obstruction and abnormal pressure
□ Abnormal bubble detecting: Bubbles in the pipeline fail to be recognize and no alarming
□ Unreasonable alarming: Normal infusion with frequently unreasonable alarming
□ Alarming out of order: Not alarming when the infusion cumulative amount reaches a preset level
IP = infusion pump; AE = adverse event
Volume 6 Issue 7 -2022 Research Article
clinicsofoncology.com 3
3.2. Patient Population
The "before" group enrolled all patients in neonatology from May
2019 to April 2020 (before the RCA approach), and the "after"
group enrolled all patients from May 2020 to December 2020
(during the active RCA approach).
3.3. Intervention
RCA group members, a total of 8, came from different depart-
ments. It included as follow: one charge nurse who acted as team
leader; three duty nurses; one teaching secretary; one inpatient
instrument manager; one IP manager who came from device de-
partment; and one doctor. To meet the requirements of the RCA
Table 2. RCAApproach.
team, the head of neonatal pediatrics distributed a memorandum
to hospital management describing the study and asked employees
to do their best to respond to the recommendations of the study.
The study team followed the RCA framework to determine the
root cause of AEs and developed management plans to prevent
AE recurrence (Table 2). In brief, the study team applied a "brain-
storming method" to deeply analyze the causes of AEs in IP-used
infusion by the “fishbone” diagram method, and used the 80 / 20
rule to solve problems. By using an online AE reporting system,
we promptly obtained the data and managed the follow-up of these
recommendations.
Step Description
What happened?
Identification of AEs The responsible nurse identified events during daily rounds
Determination of AEs Risk assessment using the AE Severity Rating (Appendix 2)
Consequences of AEs Ⅱ-Ⅳ level events
RCA team
The team was multidisciplinary and included: one head nurse serving as the group leader, one doctor,
three responsible leaders of the ward, one teaching secretary, one instrument manager of the ward and one
full-time IP manager from the device department
Gather information
The researcher investigated the AEs. This included data review and interviews with anyone closely
related to the event. Collecting information including the children’s general information, nurse
qualifications, AE happening conditions, IP maintenance records, and etc.
Events recovering Discussions with the nursing staff to recover the situation, and checking IP and records on site
RCA meeting The RCA team meeting that lasted 2 to 3h and developed preliminary implementation plans
Why did it happen?
Determination of contributing factors
Using "brainstorming method" combined with “fishbone” diagram and “5WHY” to gather the
contributing factors focusing on five aspects of "human, machine, material, method and environment"
and the following three questions: why did it happen? Why didn't find out in time? Why there was no
systematic prevention of these events?
Determination of root causes
RCA meeting to answer the following three questions (“Yes" is the proximal cause, otherwise is the
root cause): 1) Does the event re-occur when the cause does not exist? 2) If the cause is corrected or
eliminated, will the event re-occur due to the same factor? 3) Can similar AEs re-occur after the cause is
corrected or eliminated?
How to prevent recurrence?
Action plans
Found potential solutions to the raised issues, and action plans were made carefully. Strengthened the
action plans and promised the recommendations which would clear up or control similar future events.
Plan implementation
Every RCA team focused on an improved plan and followed its implementation. The team met every 2
weeks to report on the plan implementation.
Assessment of outcomes
To assess the effectiveness of each recommendation and measure the incidence of all events before and
after the RCA approach.
RCA = root cause analysis;IP = infusion pump;AE = adverse event.
Volume 6 Issue 7 -2022 Research Article
clinicsofoncology.com 4
3.4. Outcomes
Firstly, it was a difference in the incidence of AEs before and after
the RCA approach. Secondly, it included the process of root cause
identification for each AE, how many recommendations raised,
and how many recommendations completed.
3.5. Statistical Analysis
The ratios of IP-related AEs between before and after RCA groups
were compared by Chi-square tests, or by Fisher exact tests when
n < 5, by using SPSS 23.0 (SPSS, USA). P < 0.05 was considered
statistically significant.
4. Results
4.1. Patients and AEs
During the RCA approach period, from May 2019 to April 2020,
a total of 4,624 patients were included (see Figure 1). There was a
total of 12 AEs tracked.
Figure 1. Study flow diagram. RCA = root cause analysis; AE = adverse
event; IP = infusion pump.
Table 3. AE rates of before and after RCA approach
4.2. The Ratios of IP-Related AEs before the RCAApproach
There were 3,180 patients (9,880 cases of infusion) in the before
RCA group with 12 AEs. The most common AEs were IP alarming
malfunction, IP malfunction and medication error (All 3 AEs were
wrong speed settings in IP programming). (See Table 3). General
information of 12 neonates with IP-related AEs was as follow: 7
boys and 5 girls; 8 full-term infants and 4 premature infants (ges-
tational age 35.2 W); 3-26 days old (10.4 ± 7.1 d); 34.0-40.0 weeks
old (37.5 ± 2.0 W); birth weight 1910-3670g (3044.1 ± 596.5 g);
premature infants (4), neonatal hypopharyngeal syndrome (3),
neonatal duodenal obstruction (3), neonatal enteritis (1) and neo-
natal hyperbilirubinemia (1). The severity rating of AEs, basing
on their impacts after happening, is also essential for dealing with
the AEs promptly and reducing its impacts completely. Accord-
ing to the international Severity Assessment Code (SAC) grading
method for AEs 15, in the study, of the 12 AEs, 5 were grade IV
(41.6%), 5 were grade III (41.6%), and the remaining 2 were to
grade II (16.6%).
4.4. The Ratios of IP-Related AEs During the RCAApproach
There were 1,444 patients (5,840 cases of infusion) in the after
RCA group with 0 AEs. The AE incidence (0.00%) was signifi-
cantly less than that of the before RCA approach group (1.46%) (P
< 0.05, Table 3).
Study period Before-RCA Before vs. After (Proportion) Before vs. After (Fisher)
Date range May 2019 to April 2020
IP alarming malfunction 5(0.61%) 0.103 0.171
IP malfunction 4(0.49%) 0.144 0.305
Medication error 3(0.36%) 0.206 0.556
All 12(1.46%)
IP infusion totals 8226
Study period After-RCA
Date range May 2020 to December 2020
All 0(0.00%) 0.011 0.011
IP infusion totals 4380
RCA = root cause analysis;IP = infusion pump;AE = adverse event
Volume 6 Issue 7 -2022 Research Article
clinicsofoncology.com 5
4.5. RCA Results
In the study, 14 root causes (Appendix 1) were founded and rec-
ommendations were raised separately. The number of root caus-
es (and corresponding solutions) was varied from 1 to 3 for each
RCA. The most common recommendations included: upgrading
IP system, and training the nurses basing on their levels with em-
phasis on the operational norms and safety awareness. The most
root cause and recommendation type were the too low version of
Appendix 1. Root Causes, action plans, and their status.
IP software system which resulted in IP alarming malfunction and
IP malfunction (75%). The other was the weak IP safety awareness
and nonstandard IP operation for junior nurses (25%). Of the 14
recommendation types, 3 were "elimination", and the remaining
11 were "control". At the end of the study, the status of 14 recom-
mendations was that 12 (85.7%) had been "completed" and two
(14.3%) would be "to be completed".
Root Cause Recommendation Action Type Status
Persons
1
Junior nurses have weak safety awareness
and nonstandard IP operation
The teaching secretary trained the nurses in different levels,
focusing on the IP operational norms and safety awareness
Control Completed
2
There are many uncertain factors in clinical
practice, and the nurse allocation mode is
not reasonable
The head nurse shall allocate manpower reasonably according
to human resources, set standby shift, and start standby shift
if necessary
Control Completed
3
The head nurse's supervision of IP safety
is not enough, especially on weekends,
holidays and at night
The head nurse included the IP AEs into the department’s
sensitive index management, and set up a team leader to
assist in supervising the work quality, covering every period
Control Completed
4
There is no routine inspection from the
device department
The device department made a routine inspection by once
every two weeks
Control Completed
5
IP manufacturers have no routine testing
and calibration
The IP manufacturer made a routine inspection and
calibration by once a quarter
Control Completed
6
There are obstacles in the cooperation and
communication between clinical, device and
other departments, and manufacturers
Established the "DingDing" interactive communication
platform to deal with events in a timely manner
Control Completed
Machines
7 IP hardware aging
Set up a ward instrument administrator, responsible for
checking the time-limit of instrument use by once a month
Control Completed
8
The shallow groove of the infusion tube is
easy to cause the tube bending and affects
the accuracy of infusion
IP manufacturer replaced all the shallow grooves
Eliminate To be
completed
9
The version of IP software system is too
low
Upgraded IP system to the highest version
Eliminate Completed
Materials
10
The IP model is frequently changed, so it is
not immediately known for users
Contacted the purchasing department to minimize the
changing of IP model. Otherwise, be sure to inform the
clinical and device department in advance
Control Completed
Methods
11 The IP SOP is not perfect
The group revised the IP SOP, and posted the SOP on the IP
in the form of two-dimensional code. The user only needs
to scan WeChat code to view the SOP and the maintenance
record
Eliminate
Completed
12
The clinical training is too rigid, and in
the past, it emphasized on IP use but the
identification and coping of infusion safety
risk factors
The teaching secretary developed a multi-department training
plan in addition to the regular training to improve the IP
safety-controlling abilities of nurses
Control Completed
Environments
13
Lack of a checklist for safe IP infusion,
including critical time points during IP
infusion, inspections, and shifts
Set up a checklist for safe IP infusion, and the nurse should
mark during the execution, so as to facilitate the work quality
Control Completed
Volume 6 Issue 7 -2022 Research Article
clinicsofoncology.com 6
14
The MOBILE data terminal (PDA) and
hospital information HIS system is not
perfectly cooperated for IP infusion and
inspection
Communicated with information department to optimize HIS
system, extracting the needed information through barcode.
During IP infusion patrols, PDA interface may prompt the
infusion speed, infusion volume, estimated infusion ending
time and other information, so as to assist nurses to judge IP
infusion overview
Control To be
completed
PDA = personal digital assistant; RCA = root cause analysis;IP = infusion pump;AE = adverse event; SOP = standard operating procedure
5. Discussion
The study performed at a national hospital yielded information on
12 AEs in 4624 neonatal patients. The RCA approach in these AEs
(over 8 months) produced 14 recommendations, of which 85.7%
were completed. The RCA-induced impact on patient safety was
that the overall AE ratio was decreased from 1.46% to 0.00%.
RCA was correlated with a decreasing of AE incidence. The two
main root causes found in RCA approach were that the IP soft-
ware system version is too low which subsequently results in IP
alarming malfunction and IP malfunction, and the weak IP safety
awareness and nonstandard IP operation for junior nurses. The too
low version of IP software system, i.e., a prior version may not
have advanced features but should not allow AEs from happening
basing on the results of application at that time, is an independent
risk factor for AEs 16, which results in infusion to be too fast, too
slow or unstable, and sometimes the infusion will automatically
stop or exceed the required amounts, endangering the life safe-
ty of neonates. IP alarming malfunction is mainly caused by the
operator pressing the return key during infusion, resulting in the
early infusion amount excluded from the expected final infusion
cumulative amount, i.e. there was a loophole of the program 17.
In 4 AEs of IP malfunction: 1 was the increased infusion speed
due to the bending of the infusion tube inside the machine, and
the other 3 were caused by problems of IP programming. We put
forward 5 improvements for these AEs [18]. First, the IP operat-
ing system must upgrade to the latest version, and the system’s
maximum infusion speed set at 30ml / h because the IP is gener-
ally used for routine rehydration in neonatology and the infusion
speed is generally less than 30ml / h. Secondly, we add a “drip-
clip” infusion mode, when the IP detects a deviation of the actual
infusion speed from the preset speed (≥ 20%) and it will alarm
and stop infusion automatically. The third is to add infusion-tube
grooves inside the IP machine, to avoid the irrespective rapid in-
fusion due to the infusion tube bending. The fourth is to upgrade
the system to a non-answer mode during infusion, i.e., no matter
what keys pressed during infusion, the calculation of cumulative
quantity would not be affected, hence avoiding no alarming when
the cumulative amount is greater than the preset amount. Finally,
the device department and IP manufacturer formulates a routine
maintenance of IPs, including the device department staff patrols
once every two weeks and the IP manufacturer staff maintains the
calibration once every quarter, so as to ensure the safety of use of
IPs. Next, the implement of neonatal nursing-core-system being
far from satisfactory, is the most fundamental cause of AEs. For
example, three errors of infusion speed settings manifested in the
wrong decimal position, in which the demanded speed of 6.5ml / h,
10.9ml / h and 13.9ml / h was set to 65ml / h, 109ml / h and 139ml
/ h respectively. The severe events showed that the nurses did not
perform “three checks and seven reviews” for infusion and did not
finish a full inspection during the infusion. In order to improve the
safety, the head nurse included IP Infusion Safety into the sensitiv-
ity-index of ward management and set it to the target value 19,20,
i.e. collecting, analyzing, managing, tracking and feedbacking the
results every quarter, and summarizing the results in the fourth
quarter of the year. The responsible-group leader strengthened
the quality-control of each section of IP Infusion Safe, randomly
checked the implementation every week. The group also made a
brief verification list for this section (Appendix 2). In brief, the
nurses set parameters according to the doctor's advice, and co-
checked by two partners before IP infusion; and they must carry
out a procedure followed the brief verification list during the infu-
sion, and then patrol and shift handover.
Furthermore, we found that junior nurses were the higher risk
group for IP-related AEs 21. Among 12-AE-related nurses, 58%
(7/12) have been working for 3-5 years. Similar results were also
observed in China 22. The teaching secretary made a detailed hier-
archical training plan for nurses in neonatology and implemented
it: aiming to increase the levels of IP-operating proficiency (work-
ing years: < 3), the sense of responsibility and safety awareness
(working years: 3-5), and the abilities of the quality control and
supervision of clinical teaching and training (working years: >
5). Night-day shift at noon and weekend/holiday are the high risk
time windows of AEs 23. Among 12 AEs, 75% (9 / 12) were hap-
pened on weekend/holiday as well as 67% (8 / 12) were at night;
while in day time, working in succession at noon (33%, 4 / 12) was
common, which might be due to the less supervision and the lack-
ing of responsibility. The group leader with working years over
5 in the neonatal department, set up recommendations for each
time window, and arranged the shift reasonably according to the
nurse's matching level. The advantages of the study are as follows:
a thorough RCA approach was adopted, a large number of neona-
tal patients were enrolled, multidisciplinary cooperation and the
participation of hospital leaders, and an online reporting system
was implemented to ensure the implementation of the recommen-
dations. The lower incidence of AEs during the RCA approach
further indicates the above strengths. However, a pre–post design
Volume 6 Issue 7 -2022 Research Article
clinicsofoncology.com 7
of the study has limitations that it does not parallel control for de-
tecting the changes apart from the RCA intervention. It is possible
that some of the decreasing of AE incidences could be attributed
to factors such as improved employee education, greater emphasis
on safety by departments and hospital management, better man-
agement of comorbidities, etc. other than the RCA approach itself.
The RCA approach of the study also offers numerous advantag-
es, such as encouraging employees to solve system problems and
make suggestions, especially those provided by the RCA group
members (senior employees) had a higher credibility which in turn
would improve the implementation of these suggestions (Table 4).
Table 4. Advantages and disadvantages of the RCA approach
Advantages
□ RCA is a powerful tool to find problems from a learning system level
□ The approach increases the credibility of the raised issues and suggestions
□ The process ensures that every attributing root cause has certain potential solutions
□ For AEs, clinical staff can state that they have done their best to determine what happened and how to prevent them happened again in the
future
Disadvantages
□ The RCA process takes time and effort
□ Subsequent designees who did not attend RCA meetings are unlikely to accept the recommendations
□ RCA results depend in part on the views of the participants
□ If RCA is not a part of the hospital mainstream safety process, the hospital management department will not make timely and important
responses to the recommendations
□ Although some recommendations are credible, they may not work due to the lack of funds in hospitals
RCA = root cause analysis; AE = adverse event
Appendix 2. Brief verification list for IP safety in department of neonatology.
Checking items
Shift transition
Random
checking
(Y or N)
Day(Y or N)
Night(17:30-1:00)
(Y or N)
Night(1:00-8:30)
(Y or N)
Starting IP infusion
Two partners co-checking the setting
parameters
Checking whether the IP model matches
Marking the liquid level
Checking whether the drip clamp fixed
properly
During inspection
Checking the decreasing range of liquid level
and mark the level every 4h
Checking whether the dropping speed of drip
clip is consistent with the pumping speed
Changing the position of peristaltic infusion
tube every 4h
Checking whether the change of working
interface parameters of IP meets the
requirements
During the shift change
Checking whether the fixation of IP tube
meets the requirements
Marking the liquid level
Recording the cumulative infusion volume
Checking the running status of the machine
IP = infusion pump
Volume 6 Issue 7 -2022 Research Article
clinicsofoncology.com 8
6. Conclusions
Although the equipment of IP can accurately control the total
amount and flow rate of infusion and significantly reduce the
workload of neonatal nursing, the IP-related AEs are still hap-
pened from time to time. RCA, a strategy to find the cause of an
AE and prevent the same AE from happening again, was used in
this study. We enrolled a large number of neonatal patients, and ap-
plied a pre–post design. The RCA approach (8 months) produced
14 unique recommendations, 85.7% of which were completed. We
found that RCA approach greatly improved the overall safety of
the system of IP-used infusions in neonates, and specifically re-
duced the incidence of IP related errors. The study has many ad-
vantages, such as a thorough RCA approach was adopted, a large
number of neonatal patients were enrolled, multidisciplinary co-
operation and the participation of hospital leaders, and an online
reporting system was implemented to ensure the implementation
of the recommendations. However, a pre–post design of the study
has limitations that it does not parallel control for detecting the
changes apart from the RCA intervention, and a system level RCA
study in which nationally participating hospitals are randomly as-
signed to the RCA approach is needed.
7. Acknowledgments
The authors declare no competing interests. This publication was
supported by the Natural Science Foundation of the Department of
Education of Zhejiang Province (Y202045544).
References
1. Okoro PE. Accuracy of fluid delivery devices for the neonate: Are
the measures assured? Nigerian journal of clinical practice. 2020;
23(8): 1044-1047.
2. Anderson BJ, Hodkinson B. Are there still limitations for the use of
target-controlled infusion in children? Current opinion in anaesthesi-
ology. 2010; 23(3): 356-362.
3. Tejavej A. Neonatal intensive care: present and future trends in Thai-
land. Journal of the Medical Association of Thailand = Chotmaihet
thangphaet. 1993; 76 Suppl 2: 114-118.
4. Ribeiro Gda S, Silva RC, Ferreira Mde A, Silva GR. Slips, lapses and
mistakes inthe use of equipment by nurses in an intensive care unit.
Revista da Escola de Enfermagem da U S P. 2016; 50(3): 419-426.
5. McElroy LM. Applying the WHO conceptual framework for the In-
ternational Classification for Patient Safety to a surgical population.
International journal for quality in health care: journal of the Inter-
national Society for Quality in Health Care. 2016; 28(2): 166-174.
6. Sullivan JE, Buchino JJ. Medication errors in pediatrics--the octopus
evading defeat. Journal of surgical oncology. 2004; 88(3): 182-188.
7. Snijder RA. Dosing errors in preterm neonates due to flow rate vari-
ability in multi-infusion syringe pump setups: An in vitro spectro-
photometry study. European journal of pharmaceutical sciences: offi-
cial journal of the European Federation for Pharmaceutical Sciences.
2016; 93: 56-63.
8.
Bergon-Sendin E. Smart pumps and random safety audits in a Neo-
natal Intensive Care Unit: a new challenge for patient safety. BMC
pediatrics. 2015; 15: 206.
9. Kunac DL, Reith DM. Identification of priorities for medication
safety in neonatal intensive care. Drug safety. 2005; 28(3): 251-261.
10. Jun JH. Efficacy of forced-air warming and warmed intravenous
fluid for prevention of hypothermia and shivering during caesarean
delivery under spinal anaesthesia: A randomised controlled trial. Eu-
ropean journal of anaesthesiology. 2019; 36(6): 442-448.
11. Wang R. Heparin Saline Versus Normal Saline for Flushing and
Locking Peripheral Venous Catheters in Decompensated Liver Cir-
rhosis Patients: A Randomized Controlled Trial. Medicine. 2015;
94(31): e1292.
12. Sugimoto M. Prevention of venous pain and phlebitis caused by epi-
rubicin hydrochloride. Gan to kagaku ryoho. Cancer & chemothera-
py. 2009; 36(6): 969-974.
13. Roswell RO. Intravenous heparin dosing strategy in hospitalized pa-
tients with atrial dysrhythmias. Journal of thrombosis and thrombol-
ysis. 2016; 42(2): 179-185.
14. Bagian JP. The Veterans Affairs root cause analysis system in ac-
tion. The Joint Commission journal on quality improvement. 2002;
28(10): 531-545.
15. Switaj TL, Cummings BM, Logan MS, Mort EA. Adopting RCA
(2): The Interrater Reliability of Safety Assessment Codes. American
journal of medical quality: the official journal of the American Col-
lege of Medical Quality. 2019; 34(2): 152-157.
16. Jani YH, Chumbley GM, Furniss D, Blandford A, Franklin B. The
Potential Role of Smart Infusion Devices in Preventing or Contrib-
uting to Medication Administration Errors: A Descriptive Study of 2
Data Sets. Journal of patient safety. 2020.
17. Glover KR, Vitoux RR, Schuster C, Curtin CR. Types and Frequency
of Infusion Pump Alarms: Protocol for a Retrospective Data Analy-
sis. JMIR research protocols. 2018; 7(6): e10446.
18. Smigielski R. Hardening Infusion Pump Communication Software
for Medical Device Cybersecurity. Biomedical instrumentation &
technology. 2017; 51(s6): 46-51.
19. Schnider TW, Minto CF, Struys MM, Absalom AR. The Safety
of Target-Controlled Infusions. Anesthesia and analgesia. 2016;
122(1): 79-85.
20. 20. Absalom A. Target-Controlled Infusion: A Mature Technology.
Anesthesia and analgesia. 2016; 122(1): 70-78.
21. Atwal A, Phillip M, Moorley C. Senior nurses’ perceptions of junior
nurses’ incident reporting: A qualitative study. Journal of nursing
management. 2020; 28(6): 1215-1222.
22. Ewing, G. et al. Role and experience determine decision support in-
terface requirements in a neonatal intensive care environment. Jour-
nal of biomedical informatics. 2003; 36(4-5): 240-249.
23. Maziero, E. C. S. et al. Association between nursing work conditions
and adverse events in neonatal and pediatric Intensive Care Units.
Revista da Escola de Enfermagem da U S P. 2020; 54(e03623.

More Related Content

Similar to A Large Sample Single Center Study On Reducing the Incidence of Adverse Events During Intravenous Pump-Used Infusion in Neonates by Root Cause Analysis

Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...
Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...
Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...Healthcare and Medical Sciences
 
Current Pharmacovigilance Practice And Improving Methods
Current Pharmacovigilance Practice And Improving MethodsCurrent Pharmacovigilance Practice And Improving Methods
Current Pharmacovigilance Practice And Improving Methodsavinashkhairnar
 
Practicum Presentation
Practicum PresentationPracticum Presentation
Practicum Presentationguest231e1f
 
Pediatric Adverse Drug Events Presentation
Pediatric Adverse Drug Events PresentationPediatric Adverse Drug Events Presentation
Pediatric Adverse Drug Events PresentationJordan Gamart
 
Strengthening IPC in primary care.pptx
Strengthening IPC in primary care.pptxStrengthening IPC in primary care.pptx
Strengthening IPC in primary care.pptxMedicalSuperintenden19
 
Digital evidence year in review-2017
Digital evidence year in review-2017Digital evidence year in review-2017
Digital evidence year in review-2017Kent State University
 
M01 Introduction to EID and POC EID Testing.pptx
M01 Introduction to EID and POC EID Testing.pptxM01 Introduction to EID and POC EID Testing.pptx
M01 Introduction to EID and POC EID Testing.pptxDagneBodena1
 
Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...
Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...
Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...soad shedeed
 
Anti-D Presentation - Anti-D Lessons from SHOT - Serious Hazards of Transfusi...
Anti-D Presentation - Anti-D Lessons from SHOT - Serious Hazards of Transfusi...Anti-D Presentation - Anti-D Lessons from SHOT - Serious Hazards of Transfusi...
Anti-D Presentation - Anti-D Lessons from SHOT - Serious Hazards of Transfusi...mhinfostore
 
JE_clinical_care_guidelines_PATH.html
JE_clinical_care_guidelines_PATH.htmlJE_clinical_care_guidelines_PATH.html
JE_clinical_care_guidelines_PATH.htmlSiti Mastura
 
Hiv prophylaxis-following-occupational-exposure-12-04-2012
Hiv prophylaxis-following-occupational-exposure-12-04-2012Hiv prophylaxis-following-occupational-exposure-12-04-2012
Hiv prophylaxis-following-occupational-exposure-12-04-2012Masbelle Opencel
 
Management of HIV - Post-Exposure Prophylaxis Management of HIV - Post-Expo...
Management of HIV - Post-Exposure Prophylaxis 	 Management of HIV - Post-Expo...Management of HIV - Post-Exposure Prophylaxis 	 Management of HIV - Post-Expo...
Management of HIV - Post-Exposure Prophylaxis Management of HIV - Post-Expo...MedicineAndHealthUSA
 
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...hiij
 
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...hiij
 
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...hiij
 
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...hiij
 
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...hiij
 
Prevalence of Anamiea and Its Predictors in Pregnant Women Attending Antenata...
Prevalence of Anamiea and Its Predictors in Pregnant Women Attending Antenata...Prevalence of Anamiea and Its Predictors in Pregnant Women Attending Antenata...
Prevalence of Anamiea and Its Predictors in Pregnant Women Attending Antenata...iosrjce
 

Similar to A Large Sample Single Center Study On Reducing the Incidence of Adverse Events During Intravenous Pump-Used Infusion in Neonates by Root Cause Analysis (20)

Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...
Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...
Prognostic Value of Serum Amyloid A Protein in Egyptian Infants with Hypoxic ...
 
Current Pharmacovigilance Practice And Improving Methods
Current Pharmacovigilance Practice And Improving MethodsCurrent Pharmacovigilance Practice And Improving Methods
Current Pharmacovigilance Practice And Improving Methods
 
Practicum Presentation
Practicum PresentationPracticum Presentation
Practicum Presentation
 
Pediatric Adverse Drug Events Presentation
Pediatric Adverse Drug Events PresentationPediatric Adverse Drug Events Presentation
Pediatric Adverse Drug Events Presentation
 
Strengthening IPC in primary care.pptx
Strengthening IPC in primary care.pptxStrengthening IPC in primary care.pptx
Strengthening IPC in primary care.pptx
 
Digital evidence year in review-2017
Digital evidence year in review-2017Digital evidence year in review-2017
Digital evidence year in review-2017
 
AEFI guidelines
AEFI guidelinesAEFI guidelines
AEFI guidelines
 
M01 Introduction to EID and POC EID Testing.pptx
M01 Introduction to EID and POC EID Testing.pptxM01 Introduction to EID and POC EID Testing.pptx
M01 Introduction to EID and POC EID Testing.pptx
 
Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...
Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...
Incidence and-etiology-of-acute-kidney-injury-in-children-admitted-to-picuusi...
 
Anti-D Presentation - Anti-D Lessons from SHOT - Serious Hazards of Transfusi...
Anti-D Presentation - Anti-D Lessons from SHOT - Serious Hazards of Transfusi...Anti-D Presentation - Anti-D Lessons from SHOT - Serious Hazards of Transfusi...
Anti-D Presentation - Anti-D Lessons from SHOT - Serious Hazards of Transfusi...
 
JE_clinical_care_guidelines_PATH.html
JE_clinical_care_guidelines_PATH.htmlJE_clinical_care_guidelines_PATH.html
JE_clinical_care_guidelines_PATH.html
 
Hiv prophylaxis-following-occupational-exposure-12-04-2012
Hiv prophylaxis-following-occupational-exposure-12-04-2012Hiv prophylaxis-following-occupational-exposure-12-04-2012
Hiv prophylaxis-following-occupational-exposure-12-04-2012
 
Management of HIV - Post-Exposure Prophylaxis Management of HIV - Post-Expo...
Management of HIV - Post-Exposure Prophylaxis 	 Management of HIV - Post-Expo...Management of HIV - Post-Exposure Prophylaxis 	 Management of HIV - Post-Expo...
Management of HIV - Post-Exposure Prophylaxis Management of HIV - Post-Expo...
 
slt siwes report
slt siwes reportslt siwes report
slt siwes report
 
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
 
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
 
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
 
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
 
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
IMPACT OF HEALTH INFORMATICS TECHNOLOGY ON THE IMPLEMENTATION OF A MODIFIED E...
 
Prevalence of Anamiea and Its Predictors in Pregnant Women Attending Antenata...
Prevalence of Anamiea and Its Predictors in Pregnant Women Attending Antenata...Prevalence of Anamiea and Its Predictors in Pregnant Women Attending Antenata...
Prevalence of Anamiea and Its Predictors in Pregnant Women Attending Antenata...
 

More from JohnJulie1

Anemia in The Patient with Cancer
Anemia in The Patient with CancerAnemia in The Patient with Cancer
Anemia in The Patient with CancerJohnJulie1
 
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...JohnJulie1
 
Abnormal Sodium and Chlorine Level Is Associated With Prognosis of Lung Cance...
Abnormal Sodium and Chlorine Level Is Associated With Prognosis of Lung Cance...Abnormal Sodium and Chlorine Level Is Associated With Prognosis of Lung Cance...
Abnormal Sodium and Chlorine Level Is Associated With Prognosis of Lung Cance...JohnJulie1
 
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...JohnJulie1
 
Diagnostic Accuracy of Raised Platelet to Lymphocyte Ratio in Predicting Heli...
Diagnostic Accuracy of Raised Platelet to Lymphocyte Ratio in Predicting Heli...Diagnostic Accuracy of Raised Platelet to Lymphocyte Ratio in Predicting Heli...
Diagnostic Accuracy of Raised Platelet to Lymphocyte Ratio in Predicting Heli...JohnJulie1
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...JohnJulie1
 
Breast Anatomy
Breast AnatomyBreast Anatomy
Breast AnatomyJohnJulie1
 
Alterations of Gut Microbiota From Colorectal Adenoma to Carcinoma
Alterations of Gut Microbiota From Colorectal Adenoma to CarcinomaAlterations of Gut Microbiota From Colorectal Adenoma to Carcinoma
Alterations of Gut Microbiota From Colorectal Adenoma to CarcinomaJohnJulie1
 
Prognosis of Invasive Micropapillary Carcinoma of the Breast Analyzed by Usin...
Prognosis of Invasive Micropapillary Carcinoma of the Breast Analyzed by Usin...Prognosis of Invasive Micropapillary Carcinoma of the Breast Analyzed by Usin...
Prognosis of Invasive Micropapillary Carcinoma of the Breast Analyzed by Usin...JohnJulie1
 
Uretero-Enteric Anastomosis Stricture after Urinary Diversion; Detailed Analy...
Uretero-Enteric Anastomosis Stricture after Urinary Diversion; Detailed Analy...Uretero-Enteric Anastomosis Stricture after Urinary Diversion; Detailed Analy...
Uretero-Enteric Anastomosis Stricture after Urinary Diversion; Detailed Analy...JohnJulie1
 
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...JohnJulie1
 
Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...
Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...
Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...JohnJulie1
 
Update on Muscle Channelopathy
Update on Muscle ChannelopathyUpdate on Muscle Channelopathy
Update on Muscle ChannelopathyJohnJulie1
 
The Use of the Infrared Laser Therapy of 890-910 NM for the Treatment Breast ...
The Use of the Infrared Laser Therapy of 890-910 NM for the Treatment Breast ...The Use of the Infrared Laser Therapy of 890-910 NM for the Treatment Breast ...
The Use of the Infrared Laser Therapy of 890-910 NM for the Treatment Breast ...JohnJulie1
 
Prevalence of Hpv Infection in the Lekoumou and Niari Departments (Congo Braz...
Prevalence of Hpv Infection in the Lekoumou and Niari Departments (Congo Braz...Prevalence of Hpv Infection in the Lekoumou and Niari Departments (Congo Braz...
Prevalence of Hpv Infection in the Lekoumou and Niari Departments (Congo Braz...JohnJulie1
 
Upper Rectal Cancer: Benefit After Preoperative Chemoradiation Versus Upfront...
Upper Rectal Cancer: Benefit After Preoperative Chemoradiation Versus Upfront...Upper Rectal Cancer: Benefit After Preoperative Chemoradiation Versus Upfront...
Upper Rectal Cancer: Benefit After Preoperative Chemoradiation Versus Upfront...JohnJulie1
 
Follow-Up Strategies in Focal Liver Lesions And Treatment Methods
Follow-Up Strategies in Focal Liver Lesions And Treatment MethodsFollow-Up Strategies in Focal Liver Lesions And Treatment Methods
Follow-Up Strategies in Focal Liver Lesions And Treatment MethodsJohnJulie1
 
Contextual Factors Associated with Health-Related Quality of Life in Older Ad...
Contextual Factors Associated with Health-Related Quality of Life in Older Ad...Contextual Factors Associated with Health-Related Quality of Life in Older Ad...
Contextual Factors Associated with Health-Related Quality of Life in Older Ad...JohnJulie1
 
Pancreatic Adenocarcinoma with Isolated Venous Involvement: Is Neoadjuvant Tr...
Pancreatic Adenocarcinoma with Isolated Venous Involvement: Is Neoadjuvant Tr...Pancreatic Adenocarcinoma with Isolated Venous Involvement: Is Neoadjuvant Tr...
Pancreatic Adenocarcinoma with Isolated Venous Involvement: Is Neoadjuvant Tr...JohnJulie1
 
Predictive Value of Biomarkers Fibrinogen Like Protein-2 and A-Fetoprotein fo...
Predictive Value of Biomarkers Fibrinogen Like Protein-2 and A-Fetoprotein fo...Predictive Value of Biomarkers Fibrinogen Like Protein-2 and A-Fetoprotein fo...
Predictive Value of Biomarkers Fibrinogen Like Protein-2 and A-Fetoprotein fo...JohnJulie1
 

More from JohnJulie1 (20)

Anemia in The Patient with Cancer
Anemia in The Patient with CancerAnemia in The Patient with Cancer
Anemia in The Patient with Cancer
 
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
Drug Repurposing: Recent Advancements, Challenges, and Future Therapeutics fo...
 
Abnormal Sodium and Chlorine Level Is Associated With Prognosis of Lung Cance...
Abnormal Sodium and Chlorine Level Is Associated With Prognosis of Lung Cance...Abnormal Sodium and Chlorine Level Is Associated With Prognosis of Lung Cance...
Abnormal Sodium and Chlorine Level Is Associated With Prognosis of Lung Cance...
 
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...
 
Diagnostic Accuracy of Raised Platelet to Lymphocyte Ratio in Predicting Heli...
Diagnostic Accuracy of Raised Platelet to Lymphocyte Ratio in Predicting Heli...Diagnostic Accuracy of Raised Platelet to Lymphocyte Ratio in Predicting Heli...
Diagnostic Accuracy of Raised Platelet to Lymphocyte Ratio in Predicting Heli...
 
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...
 
Breast Anatomy
Breast AnatomyBreast Anatomy
Breast Anatomy
 
Alterations of Gut Microbiota From Colorectal Adenoma to Carcinoma
Alterations of Gut Microbiota From Colorectal Adenoma to CarcinomaAlterations of Gut Microbiota From Colorectal Adenoma to Carcinoma
Alterations of Gut Microbiota From Colorectal Adenoma to Carcinoma
 
Prognosis of Invasive Micropapillary Carcinoma of the Breast Analyzed by Usin...
Prognosis of Invasive Micropapillary Carcinoma of the Breast Analyzed by Usin...Prognosis of Invasive Micropapillary Carcinoma of the Breast Analyzed by Usin...
Prognosis of Invasive Micropapillary Carcinoma of the Breast Analyzed by Usin...
 
Uretero-Enteric Anastomosis Stricture after Urinary Diversion; Detailed Analy...
Uretero-Enteric Anastomosis Stricture after Urinary Diversion; Detailed Analy...Uretero-Enteric Anastomosis Stricture after Urinary Diversion; Detailed Analy...
Uretero-Enteric Anastomosis Stricture after Urinary Diversion; Detailed Analy...
 
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...
 
Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...
Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...
Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...
 
Update on Muscle Channelopathy
Update on Muscle ChannelopathyUpdate on Muscle Channelopathy
Update on Muscle Channelopathy
 
The Use of the Infrared Laser Therapy of 890-910 NM for the Treatment Breast ...
The Use of the Infrared Laser Therapy of 890-910 NM for the Treatment Breast ...The Use of the Infrared Laser Therapy of 890-910 NM for the Treatment Breast ...
The Use of the Infrared Laser Therapy of 890-910 NM for the Treatment Breast ...
 
Prevalence of Hpv Infection in the Lekoumou and Niari Departments (Congo Braz...
Prevalence of Hpv Infection in the Lekoumou and Niari Departments (Congo Braz...Prevalence of Hpv Infection in the Lekoumou and Niari Departments (Congo Braz...
Prevalence of Hpv Infection in the Lekoumou and Niari Departments (Congo Braz...
 
Upper Rectal Cancer: Benefit After Preoperative Chemoradiation Versus Upfront...
Upper Rectal Cancer: Benefit After Preoperative Chemoradiation Versus Upfront...Upper Rectal Cancer: Benefit After Preoperative Chemoradiation Versus Upfront...
Upper Rectal Cancer: Benefit After Preoperative Chemoradiation Versus Upfront...
 
Follow-Up Strategies in Focal Liver Lesions And Treatment Methods
Follow-Up Strategies in Focal Liver Lesions And Treatment MethodsFollow-Up Strategies in Focal Liver Lesions And Treatment Methods
Follow-Up Strategies in Focal Liver Lesions And Treatment Methods
 
Contextual Factors Associated with Health-Related Quality of Life in Older Ad...
Contextual Factors Associated with Health-Related Quality of Life in Older Ad...Contextual Factors Associated with Health-Related Quality of Life in Older Ad...
Contextual Factors Associated with Health-Related Quality of Life in Older Ad...
 
Pancreatic Adenocarcinoma with Isolated Venous Involvement: Is Neoadjuvant Tr...
Pancreatic Adenocarcinoma with Isolated Venous Involvement: Is Neoadjuvant Tr...Pancreatic Adenocarcinoma with Isolated Venous Involvement: Is Neoadjuvant Tr...
Pancreatic Adenocarcinoma with Isolated Venous Involvement: Is Neoadjuvant Tr...
 
Predictive Value of Biomarkers Fibrinogen Like Protein-2 and A-Fetoprotein fo...
Predictive Value of Biomarkers Fibrinogen Like Protein-2 and A-Fetoprotein fo...Predictive Value of Biomarkers Fibrinogen Like Protein-2 and A-Fetoprotein fo...
Predictive Value of Biomarkers Fibrinogen Like Protein-2 and A-Fetoprotein fo...
 

Recently uploaded

Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxbkling
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranTara Rajendran
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisGolden Helix
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfSasikiranMarri
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdfDolisha Warbi
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxvirengeeta
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiGoogle
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 

Recently uploaded (20)

Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Report Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptxReport Back from SGO: What’s New in Uterine Cancer?.pptx
Report Back from SGO: What’s New in Uterine Cancer?.pptx
 
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
Wessex Health Partners Wessex Integrated Care, Population Health, Research & ...
 
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara RajendranMusic Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
Music Therapy's Impact in Palliative Care| IAPCON2024| Dr. Tara Rajendran
 
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic AnalysisVarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
VarSeq 2.6.0: Advancing Pharmacogenomics and Genomic Analysis
 
History and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdfHistory and Development of Pharmacovigilence.pdf
History and Development of Pharmacovigilence.pdf
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
PNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdfPNEUMOTHORAX   AND  ITS  MANAGEMENTS.pdf
PNEUMOTHORAX AND ITS MANAGEMENTS.pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
POST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptxPOST NATAL EXERCISES AND ITS IMPACT.pptx
POST NATAL EXERCISES AND ITS IMPACT.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Introduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali RaiIntroduction to Sports Injuries by- Dr. Anjali Rai
Introduction to Sports Injuries by- Dr. Anjali Rai
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 

A Large Sample Single Center Study On Reducing the Incidence of Adverse Events During Intravenous Pump-Used Infusion in Neonates by Root Cause Analysis

  • 1. clinicsofoncology.com 1 Research Article ISSN: 2640-1037 Volume 6 Clinics of Oncology A Large Sample Single Center Study On Reducing the Incidence of Adverse Events During Intravenous Pump-Used Infusion in Neonates by Root Cause Analysis Shuzhen Zhu1* , Lianjuan Zhou1 , Jun Yu1 , Caixian Zheng2 , Jihua zhu3* and Kewen Jiang4* 1 Neonatology Department, Children’s Hospital Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou 310051, China 2 Device Department, Children’s Hospital Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou 310051, China 3 Department of Nursing, Children’s Hospital Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou 310051, China 4 Department of Child Psychology, The Children’s Hospital Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou 310051, China Keywords: Intravenous administration; Neonate; Infusion pump; Root cause analysis; Adverse event Abbreviations: Received: 05 May 2022 Accepted: 30 May 2022 Published: 04 Jun 2022 J Short Name: COO Copyright: ©2022 Shuzhen Zhu. This is an open access article distrib- uted under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially. Citation: Shuzhen Zhu, A Large Sample Single Center Study On Reducing the Incidence of Adverse Events During Intra- venous Pump-Used Infusion in Neonates by Root Cause Analysis. Clin Onco. 2022; 6(7): 1-8 AE: Adverse Event; IP: Infusion Pump; RCA: Root Cause Analysis; SAC: Severity Assessment Code; SPSS: Statistical Product and Service Solutions 1. Abstract Intravenous administration is one of the most critical activities in neonatology, which directly involving the use of higher precision infusion pumps. However, its related adverse events are still hap- pened during the neonatal infusion. Root cause analysis, a program to find the cause of an adverse event and prevent the same adverse event from happening again, was used in this study. We enrolled a large number of neonatal patients, and applied a pre–post design. This study resulted in information of 12 adverse events (15,720 cases of infusion with infusion pump) amongst 4,624 patients. The root cause analysis approach (8 months) produced 14 unique rec- ommendations, 85.7% of which were completed. We found that after the root cause analysis approach the overall safety of the system of infusion pump-used infusions in neonatal practices has greatly improved, and specifically a reduction in the incidence of infusion pump alarming malfunction and infusion pump malfunc- tion, and medication error due to the weak infusion pump safety awareness and nonstandard infusion pump operation for junior nurses. However, a system level root cause analysis study in which nationally participating hospitals are randomly assigned to the root cause analysis approach is needed. 2. Introduction Intravenous infusion delivering drug, nutrient and fluid is a com- mon therapeutic strategy in nursing. As a necessary clinical aux- iliary equipment, infusion pump (IP) can accurately control the total amount and flow rate of infusion and significantly reduce the workload of nursing [1-3]. It has been widely used in pediatric clinical practice including in neonatology. However, in the neo- natal IP-related nursing, adverse events (AEs) such as failures of infusion rate control, failures of IP alarming and other human fac- * Corresponding author: Shuzhen Zhu, Neonatology Department, Children’s Hospital Zhejiang University School of Medicine, National Clinical Research Center for Child Health, 3333 Binsheng Road, Hangzhou 310051, China, E-mail:jihuazhu@zju.edu.cn and jiangkw_zju@zju.edu.cn
  • 2. Volume 6 Issue 7 -2022 Research Article clinicsofoncology.com 2 tors occurring from time to time [4,5]. These errors are difficult to intercept, and their impact depends on multiple factors including the patient's drugs and conditions 6, which not only increases the suffering of patients, but also delays the recovery of diseases, in- creases medical expenses and hospital stay, and even leads to neo- natal death [7-9]. Therefore, ensuring greater safety of neonatal patients during IP-used infusion should be a priority. It has been reported that a number of strategies could reduce these IP-related AEs over the past years [10-13]. However, the AEs may still occur in neonatal infusion. The root cause analysis (RCA) approach is a strategy dealing with AEs from the level of learning system [14]. It is a retrospective analysis tool to medical AEs, from finding out the potential errors and their root causes to providing steps for pre- vention and avoiding similar AEs happening again. In this study, RCA was used prospectively in neonatology to deal with IP-used Table 1. IP AEs that were tracked and their definition infusion from May 2019 to April 2020 in a national children’s hos- pital to explore prevention and improvement steps, with ultimate goals to reduce the recurrence of AEs and ensuring the safety of neonates. 3. Methods 3.1. Design After approved by ethics board (2020-IRB-201; the Research Eth- ics Board), this study was carried out at a national children’s hos- pital. The need for participant consent was waived by the ethics committee. This was a prospective study comparing differences in the incidence of AEs (Table 1) with IP-used infusion before and after the RCA approach. IP (SN-1600V, SINOMDT, Shenzhen, China) was used in this study which would not be completely up- date during the RCA approach. It was driven by matching software (Version 1.0 to 4.0). When IP-related AE occurred, the software should upgrade to the latest version at that time. AE Definition Cardiac arrest Sudden loss of cardiac function without pulses Death Unable to be resuscitated Hypoglycemia Blood glucose < 2.2 mmol/L Hyperglycemia Blood glucose > 7.0 mmol/L Medication error Problems including the wrong drug, dose, frequency, or route of administration □ Wrong speed setting in IP program IP malfunction Did not deliver the fluid as programmed □ Uncontrolled infusion speed: Infusion speed too fast or too slow □ Uncontrolled infusion rate: Ununiformed infusion speed (sometimes fast and sometimes slow) IP programming error Errors with the IP setup or program was different from the doctor's order □ Uncontrolled infusion volume: Infusion cumulative amount being inconsistent with the setting □ Software system failure: A problem of speed settings causing the output speed to be inconsistent with the preset □ Fluid not be pumped in: Not giving liquid showing that the liquid does not drop or flow back □ Sudden not working: Suddenly not running in infusion with no alarm and unable to reboot IP mechanical failure Problems with the IP mechanical parts □ IP screen failure: Incomplete information display, low bright screen, black screen or abnormal flicker □ IP keys not working: Invalid or damaged keys □ Battery failure: Sudden power off including internal power failure or unable to recharge □ Door clamp out of order: Door unable to open or damaged IP alarming malfunction Problems with the IP alarming system □ Abnormal identifying: Not alarming or continuously light-alarming dues to unable to identify the pipeline obstruction and abnormal pressure □ Abnormal bubble detecting: Bubbles in the pipeline fail to be recognize and no alarming □ Unreasonable alarming: Normal infusion with frequently unreasonable alarming □ Alarming out of order: Not alarming when the infusion cumulative amount reaches a preset level IP = infusion pump; AE = adverse event
  • 3. Volume 6 Issue 7 -2022 Research Article clinicsofoncology.com 3 3.2. Patient Population The "before" group enrolled all patients in neonatology from May 2019 to April 2020 (before the RCA approach), and the "after" group enrolled all patients from May 2020 to December 2020 (during the active RCA approach). 3.3. Intervention RCA group members, a total of 8, came from different depart- ments. It included as follow: one charge nurse who acted as team leader; three duty nurses; one teaching secretary; one inpatient instrument manager; one IP manager who came from device de- partment; and one doctor. To meet the requirements of the RCA Table 2. RCAApproach. team, the head of neonatal pediatrics distributed a memorandum to hospital management describing the study and asked employees to do their best to respond to the recommendations of the study. The study team followed the RCA framework to determine the root cause of AEs and developed management plans to prevent AE recurrence (Table 2). In brief, the study team applied a "brain- storming method" to deeply analyze the causes of AEs in IP-used infusion by the “fishbone” diagram method, and used the 80 / 20 rule to solve problems. By using an online AE reporting system, we promptly obtained the data and managed the follow-up of these recommendations. Step Description What happened? Identification of AEs The responsible nurse identified events during daily rounds Determination of AEs Risk assessment using the AE Severity Rating (Appendix 2) Consequences of AEs Ⅱ-Ⅳ level events RCA team The team was multidisciplinary and included: one head nurse serving as the group leader, one doctor, three responsible leaders of the ward, one teaching secretary, one instrument manager of the ward and one full-time IP manager from the device department Gather information The researcher investigated the AEs. This included data review and interviews with anyone closely related to the event. Collecting information including the children’s general information, nurse qualifications, AE happening conditions, IP maintenance records, and etc. Events recovering Discussions with the nursing staff to recover the situation, and checking IP and records on site RCA meeting The RCA team meeting that lasted 2 to 3h and developed preliminary implementation plans Why did it happen? Determination of contributing factors Using "brainstorming method" combined with “fishbone” diagram and “5WHY” to gather the contributing factors focusing on five aspects of "human, machine, material, method and environment" and the following three questions: why did it happen? Why didn't find out in time? Why there was no systematic prevention of these events? Determination of root causes RCA meeting to answer the following three questions (“Yes" is the proximal cause, otherwise is the root cause): 1) Does the event re-occur when the cause does not exist? 2) If the cause is corrected or eliminated, will the event re-occur due to the same factor? 3) Can similar AEs re-occur after the cause is corrected or eliminated? How to prevent recurrence? Action plans Found potential solutions to the raised issues, and action plans were made carefully. Strengthened the action plans and promised the recommendations which would clear up or control similar future events. Plan implementation Every RCA team focused on an improved plan and followed its implementation. The team met every 2 weeks to report on the plan implementation. Assessment of outcomes To assess the effectiveness of each recommendation and measure the incidence of all events before and after the RCA approach. RCA = root cause analysis;IP = infusion pump;AE = adverse event.
  • 4. Volume 6 Issue 7 -2022 Research Article clinicsofoncology.com 4 3.4. Outcomes Firstly, it was a difference in the incidence of AEs before and after the RCA approach. Secondly, it included the process of root cause identification for each AE, how many recommendations raised, and how many recommendations completed. 3.5. Statistical Analysis The ratios of IP-related AEs between before and after RCA groups were compared by Chi-square tests, or by Fisher exact tests when n < 5, by using SPSS 23.0 (SPSS, USA). P < 0.05 was considered statistically significant. 4. Results 4.1. Patients and AEs During the RCA approach period, from May 2019 to April 2020, a total of 4,624 patients were included (see Figure 1). There was a total of 12 AEs tracked. Figure 1. Study flow diagram. RCA = root cause analysis; AE = adverse event; IP = infusion pump. Table 3. AE rates of before and after RCA approach 4.2. The Ratios of IP-Related AEs before the RCAApproach There were 3,180 patients (9,880 cases of infusion) in the before RCA group with 12 AEs. The most common AEs were IP alarming malfunction, IP malfunction and medication error (All 3 AEs were wrong speed settings in IP programming). (See Table 3). General information of 12 neonates with IP-related AEs was as follow: 7 boys and 5 girls; 8 full-term infants and 4 premature infants (ges- tational age 35.2 W); 3-26 days old (10.4 ± 7.1 d); 34.0-40.0 weeks old (37.5 ± 2.0 W); birth weight 1910-3670g (3044.1 ± 596.5 g); premature infants (4), neonatal hypopharyngeal syndrome (3), neonatal duodenal obstruction (3), neonatal enteritis (1) and neo- natal hyperbilirubinemia (1). The severity rating of AEs, basing on their impacts after happening, is also essential for dealing with the AEs promptly and reducing its impacts completely. Accord- ing to the international Severity Assessment Code (SAC) grading method for AEs 15, in the study, of the 12 AEs, 5 were grade IV (41.6%), 5 were grade III (41.6%), and the remaining 2 were to grade II (16.6%). 4.4. The Ratios of IP-Related AEs During the RCAApproach There were 1,444 patients (5,840 cases of infusion) in the after RCA group with 0 AEs. The AE incidence (0.00%) was signifi- cantly less than that of the before RCA approach group (1.46%) (P < 0.05, Table 3). Study period Before-RCA Before vs. After (Proportion) Before vs. After (Fisher) Date range May 2019 to April 2020 IP alarming malfunction 5(0.61%) 0.103 0.171 IP malfunction 4(0.49%) 0.144 0.305 Medication error 3(0.36%) 0.206 0.556 All 12(1.46%) IP infusion totals 8226 Study period After-RCA Date range May 2020 to December 2020 All 0(0.00%) 0.011 0.011 IP infusion totals 4380 RCA = root cause analysis;IP = infusion pump;AE = adverse event
  • 5. Volume 6 Issue 7 -2022 Research Article clinicsofoncology.com 5 4.5. RCA Results In the study, 14 root causes (Appendix 1) were founded and rec- ommendations were raised separately. The number of root caus- es (and corresponding solutions) was varied from 1 to 3 for each RCA. The most common recommendations included: upgrading IP system, and training the nurses basing on their levels with em- phasis on the operational norms and safety awareness. The most root cause and recommendation type were the too low version of Appendix 1. Root Causes, action plans, and their status. IP software system which resulted in IP alarming malfunction and IP malfunction (75%). The other was the weak IP safety awareness and nonstandard IP operation for junior nurses (25%). Of the 14 recommendation types, 3 were "elimination", and the remaining 11 were "control". At the end of the study, the status of 14 recom- mendations was that 12 (85.7%) had been "completed" and two (14.3%) would be "to be completed". Root Cause Recommendation Action Type Status Persons 1 Junior nurses have weak safety awareness and nonstandard IP operation The teaching secretary trained the nurses in different levels, focusing on the IP operational norms and safety awareness Control Completed 2 There are many uncertain factors in clinical practice, and the nurse allocation mode is not reasonable The head nurse shall allocate manpower reasonably according to human resources, set standby shift, and start standby shift if necessary Control Completed 3 The head nurse's supervision of IP safety is not enough, especially on weekends, holidays and at night The head nurse included the IP AEs into the department’s sensitive index management, and set up a team leader to assist in supervising the work quality, covering every period Control Completed 4 There is no routine inspection from the device department The device department made a routine inspection by once every two weeks Control Completed 5 IP manufacturers have no routine testing and calibration The IP manufacturer made a routine inspection and calibration by once a quarter Control Completed 6 There are obstacles in the cooperation and communication between clinical, device and other departments, and manufacturers Established the "DingDing" interactive communication platform to deal with events in a timely manner Control Completed Machines 7 IP hardware aging Set up a ward instrument administrator, responsible for checking the time-limit of instrument use by once a month Control Completed 8 The shallow groove of the infusion tube is easy to cause the tube bending and affects the accuracy of infusion IP manufacturer replaced all the shallow grooves Eliminate To be completed 9 The version of IP software system is too low Upgraded IP system to the highest version Eliminate Completed Materials 10 The IP model is frequently changed, so it is not immediately known for users Contacted the purchasing department to minimize the changing of IP model. Otherwise, be sure to inform the clinical and device department in advance Control Completed Methods 11 The IP SOP is not perfect The group revised the IP SOP, and posted the SOP on the IP in the form of two-dimensional code. The user only needs to scan WeChat code to view the SOP and the maintenance record Eliminate Completed 12 The clinical training is too rigid, and in the past, it emphasized on IP use but the identification and coping of infusion safety risk factors The teaching secretary developed a multi-department training plan in addition to the regular training to improve the IP safety-controlling abilities of nurses Control Completed Environments 13 Lack of a checklist for safe IP infusion, including critical time points during IP infusion, inspections, and shifts Set up a checklist for safe IP infusion, and the nurse should mark during the execution, so as to facilitate the work quality Control Completed
  • 6. Volume 6 Issue 7 -2022 Research Article clinicsofoncology.com 6 14 The MOBILE data terminal (PDA) and hospital information HIS system is not perfectly cooperated for IP infusion and inspection Communicated with information department to optimize HIS system, extracting the needed information through barcode. During IP infusion patrols, PDA interface may prompt the infusion speed, infusion volume, estimated infusion ending time and other information, so as to assist nurses to judge IP infusion overview Control To be completed PDA = personal digital assistant; RCA = root cause analysis;IP = infusion pump;AE = adverse event; SOP = standard operating procedure 5. Discussion The study performed at a national hospital yielded information on 12 AEs in 4624 neonatal patients. The RCA approach in these AEs (over 8 months) produced 14 recommendations, of which 85.7% were completed. The RCA-induced impact on patient safety was that the overall AE ratio was decreased from 1.46% to 0.00%. RCA was correlated with a decreasing of AE incidence. The two main root causes found in RCA approach were that the IP soft- ware system version is too low which subsequently results in IP alarming malfunction and IP malfunction, and the weak IP safety awareness and nonstandard IP operation for junior nurses. The too low version of IP software system, i.e., a prior version may not have advanced features but should not allow AEs from happening basing on the results of application at that time, is an independent risk factor for AEs 16, which results in infusion to be too fast, too slow or unstable, and sometimes the infusion will automatically stop or exceed the required amounts, endangering the life safe- ty of neonates. IP alarming malfunction is mainly caused by the operator pressing the return key during infusion, resulting in the early infusion amount excluded from the expected final infusion cumulative amount, i.e. there was a loophole of the program 17. In 4 AEs of IP malfunction: 1 was the increased infusion speed due to the bending of the infusion tube inside the machine, and the other 3 were caused by problems of IP programming. We put forward 5 improvements for these AEs [18]. First, the IP operat- ing system must upgrade to the latest version, and the system’s maximum infusion speed set at 30ml / h because the IP is gener- ally used for routine rehydration in neonatology and the infusion speed is generally less than 30ml / h. Secondly, we add a “drip- clip” infusion mode, when the IP detects a deviation of the actual infusion speed from the preset speed (≥ 20%) and it will alarm and stop infusion automatically. The third is to add infusion-tube grooves inside the IP machine, to avoid the irrespective rapid in- fusion due to the infusion tube bending. The fourth is to upgrade the system to a non-answer mode during infusion, i.e., no matter what keys pressed during infusion, the calculation of cumulative quantity would not be affected, hence avoiding no alarming when the cumulative amount is greater than the preset amount. Finally, the device department and IP manufacturer formulates a routine maintenance of IPs, including the device department staff patrols once every two weeks and the IP manufacturer staff maintains the calibration once every quarter, so as to ensure the safety of use of IPs. Next, the implement of neonatal nursing-core-system being far from satisfactory, is the most fundamental cause of AEs. For example, three errors of infusion speed settings manifested in the wrong decimal position, in which the demanded speed of 6.5ml / h, 10.9ml / h and 13.9ml / h was set to 65ml / h, 109ml / h and 139ml / h respectively. The severe events showed that the nurses did not perform “three checks and seven reviews” for infusion and did not finish a full inspection during the infusion. In order to improve the safety, the head nurse included IP Infusion Safety into the sensitiv- ity-index of ward management and set it to the target value 19,20, i.e. collecting, analyzing, managing, tracking and feedbacking the results every quarter, and summarizing the results in the fourth quarter of the year. The responsible-group leader strengthened the quality-control of each section of IP Infusion Safe, randomly checked the implementation every week. The group also made a brief verification list for this section (Appendix 2). In brief, the nurses set parameters according to the doctor's advice, and co- checked by two partners before IP infusion; and they must carry out a procedure followed the brief verification list during the infu- sion, and then patrol and shift handover. Furthermore, we found that junior nurses were the higher risk group for IP-related AEs 21. Among 12-AE-related nurses, 58% (7/12) have been working for 3-5 years. Similar results were also observed in China 22. The teaching secretary made a detailed hier- archical training plan for nurses in neonatology and implemented it: aiming to increase the levels of IP-operating proficiency (work- ing years: < 3), the sense of responsibility and safety awareness (working years: 3-5), and the abilities of the quality control and supervision of clinical teaching and training (working years: > 5). Night-day shift at noon and weekend/holiday are the high risk time windows of AEs 23. Among 12 AEs, 75% (9 / 12) were hap- pened on weekend/holiday as well as 67% (8 / 12) were at night; while in day time, working in succession at noon (33%, 4 / 12) was common, which might be due to the less supervision and the lack- ing of responsibility. The group leader with working years over 5 in the neonatal department, set up recommendations for each time window, and arranged the shift reasonably according to the nurse's matching level. The advantages of the study are as follows: a thorough RCA approach was adopted, a large number of neona- tal patients were enrolled, multidisciplinary cooperation and the participation of hospital leaders, and an online reporting system was implemented to ensure the implementation of the recommen- dations. The lower incidence of AEs during the RCA approach further indicates the above strengths. However, a pre–post design
  • 7. Volume 6 Issue 7 -2022 Research Article clinicsofoncology.com 7 of the study has limitations that it does not parallel control for de- tecting the changes apart from the RCA intervention. It is possible that some of the decreasing of AE incidences could be attributed to factors such as improved employee education, greater emphasis on safety by departments and hospital management, better man- agement of comorbidities, etc. other than the RCA approach itself. The RCA approach of the study also offers numerous advantag- es, such as encouraging employees to solve system problems and make suggestions, especially those provided by the RCA group members (senior employees) had a higher credibility which in turn would improve the implementation of these suggestions (Table 4). Table 4. Advantages and disadvantages of the RCA approach Advantages □ RCA is a powerful tool to find problems from a learning system level □ The approach increases the credibility of the raised issues and suggestions □ The process ensures that every attributing root cause has certain potential solutions □ For AEs, clinical staff can state that they have done their best to determine what happened and how to prevent them happened again in the future Disadvantages □ The RCA process takes time and effort □ Subsequent designees who did not attend RCA meetings are unlikely to accept the recommendations □ RCA results depend in part on the views of the participants □ If RCA is not a part of the hospital mainstream safety process, the hospital management department will not make timely and important responses to the recommendations □ Although some recommendations are credible, they may not work due to the lack of funds in hospitals RCA = root cause analysis; AE = adverse event Appendix 2. Brief verification list for IP safety in department of neonatology. Checking items Shift transition Random checking (Y or N) Day(Y or N) Night(17:30-1:00) (Y or N) Night(1:00-8:30) (Y or N) Starting IP infusion Two partners co-checking the setting parameters Checking whether the IP model matches Marking the liquid level Checking whether the drip clamp fixed properly During inspection Checking the decreasing range of liquid level and mark the level every 4h Checking whether the dropping speed of drip clip is consistent with the pumping speed Changing the position of peristaltic infusion tube every 4h Checking whether the change of working interface parameters of IP meets the requirements During the shift change Checking whether the fixation of IP tube meets the requirements Marking the liquid level Recording the cumulative infusion volume Checking the running status of the machine IP = infusion pump
  • 8. Volume 6 Issue 7 -2022 Research Article clinicsofoncology.com 8 6. Conclusions Although the equipment of IP can accurately control the total amount and flow rate of infusion and significantly reduce the workload of neonatal nursing, the IP-related AEs are still hap- pened from time to time. RCA, a strategy to find the cause of an AE and prevent the same AE from happening again, was used in this study. We enrolled a large number of neonatal patients, and ap- plied a pre–post design. The RCA approach (8 months) produced 14 unique recommendations, 85.7% of which were completed. We found that RCA approach greatly improved the overall safety of the system of IP-used infusions in neonates, and specifically re- duced the incidence of IP related errors. The study has many ad- vantages, such as a thorough RCA approach was adopted, a large number of neonatal patients were enrolled, multidisciplinary co- operation and the participation of hospital leaders, and an online reporting system was implemented to ensure the implementation of the recommendations. However, a pre–post design of the study has limitations that it does not parallel control for detecting the changes apart from the RCA intervention, and a system level RCA study in which nationally participating hospitals are randomly as- signed to the RCA approach is needed. 7. Acknowledgments The authors declare no competing interests. This publication was supported by the Natural Science Foundation of the Department of Education of Zhejiang Province (Y202045544). References 1. Okoro PE. Accuracy of fluid delivery devices for the neonate: Are the measures assured? Nigerian journal of clinical practice. 2020; 23(8): 1044-1047. 2. Anderson BJ, Hodkinson B. Are there still limitations for the use of target-controlled infusion in children? Current opinion in anaesthesi- ology. 2010; 23(3): 356-362. 3. Tejavej A. Neonatal intensive care: present and future trends in Thai- land. Journal of the Medical Association of Thailand = Chotmaihet thangphaet. 1993; 76 Suppl 2: 114-118. 4. Ribeiro Gda S, Silva RC, Ferreira Mde A, Silva GR. Slips, lapses and mistakes inthe use of equipment by nurses in an intensive care unit. Revista da Escola de Enfermagem da U S P. 2016; 50(3): 419-426. 5. McElroy LM. Applying the WHO conceptual framework for the In- ternational Classification for Patient Safety to a surgical population. International journal for quality in health care: journal of the Inter- national Society for Quality in Health Care. 2016; 28(2): 166-174. 6. Sullivan JE, Buchino JJ. Medication errors in pediatrics--the octopus evading defeat. Journal of surgical oncology. 2004; 88(3): 182-188. 7. Snijder RA. Dosing errors in preterm neonates due to flow rate vari- ability in multi-infusion syringe pump setups: An in vitro spectro- photometry study. European journal of pharmaceutical sciences: offi- cial journal of the European Federation for Pharmaceutical Sciences. 2016; 93: 56-63. 8. Bergon-Sendin E. Smart pumps and random safety audits in a Neo- natal Intensive Care Unit: a new challenge for patient safety. BMC pediatrics. 2015; 15: 206. 9. Kunac DL, Reith DM. Identification of priorities for medication safety in neonatal intensive care. Drug safety. 2005; 28(3): 251-261. 10. Jun JH. Efficacy of forced-air warming and warmed intravenous fluid for prevention of hypothermia and shivering during caesarean delivery under spinal anaesthesia: A randomised controlled trial. Eu- ropean journal of anaesthesiology. 2019; 36(6): 442-448. 11. Wang R. Heparin Saline Versus Normal Saline for Flushing and Locking Peripheral Venous Catheters in Decompensated Liver Cir- rhosis Patients: A Randomized Controlled Trial. Medicine. 2015; 94(31): e1292. 12. Sugimoto M. Prevention of venous pain and phlebitis caused by epi- rubicin hydrochloride. Gan to kagaku ryoho. Cancer & chemothera- py. 2009; 36(6): 969-974. 13. Roswell RO. Intravenous heparin dosing strategy in hospitalized pa- tients with atrial dysrhythmias. Journal of thrombosis and thrombol- ysis. 2016; 42(2): 179-185. 14. Bagian JP. The Veterans Affairs root cause analysis system in ac- tion. The Joint Commission journal on quality improvement. 2002; 28(10): 531-545. 15. Switaj TL, Cummings BM, Logan MS, Mort EA. Adopting RCA (2): The Interrater Reliability of Safety Assessment Codes. American journal of medical quality: the official journal of the American Col- lege of Medical Quality. 2019; 34(2): 152-157. 16. Jani YH, Chumbley GM, Furniss D, Blandford A, Franklin B. The Potential Role of Smart Infusion Devices in Preventing or Contrib- uting to Medication Administration Errors: A Descriptive Study of 2 Data Sets. Journal of patient safety. 2020. 17. Glover KR, Vitoux RR, Schuster C, Curtin CR. Types and Frequency of Infusion Pump Alarms: Protocol for a Retrospective Data Analy- sis. JMIR research protocols. 2018; 7(6): e10446. 18. Smigielski R. Hardening Infusion Pump Communication Software for Medical Device Cybersecurity. Biomedical instrumentation & technology. 2017; 51(s6): 46-51. 19. Schnider TW, Minto CF, Struys MM, Absalom AR. The Safety of Target-Controlled Infusions. Anesthesia and analgesia. 2016; 122(1): 79-85. 20. 20. Absalom A. Target-Controlled Infusion: A Mature Technology. Anesthesia and analgesia. 2016; 122(1): 70-78. 21. Atwal A, Phillip M, Moorley C. Senior nurses’ perceptions of junior nurses’ incident reporting: A qualitative study. Journal of nursing management. 2020; 28(6): 1215-1222. 22. Ewing, G. et al. Role and experience determine decision support in- terface requirements in a neonatal intensive care environment. Jour- nal of biomedical informatics. 2003; 36(4-5): 240-249. 23. Maziero, E. C. S. et al. Association between nursing work conditions and adverse events in neonatal and pediatric Intensive Care Units. Revista da Escola de Enfermagem da U S P. 2020; 54(e03623.